CN106518825B - A kind of chemoselective monomethylation method of coumarin catechol compound - Google Patents
A kind of chemoselective monomethylation method of coumarin catechol compound Download PDFInfo
- Publication number
- CN106518825B CN106518825B CN201510574322.1A CN201510574322A CN106518825B CN 106518825 B CN106518825 B CN 106518825B CN 201510574322 A CN201510574322 A CN 201510574322A CN 106518825 B CN106518825 B CN 106518825B
- Authority
- CN
- China
- Prior art keywords
- reaction
- coumarin
- catechol
- added
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 coumarin catechol compound Chemical class 0.000 title claims abstract description 16
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title abstract description 25
- 235000001671 coumarin Nutrition 0.000 title abstract description 19
- 229960000956 coumarin Drugs 0.000 title abstract description 17
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 title abstract description 14
- 238000000034 method Methods 0.000 title abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 42
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 36
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 14
- 239000012043 crude product Substances 0.000 claims description 11
- 239000012065 filter cake Substances 0.000 claims description 11
- 239000005457 ice water Substances 0.000 claims description 9
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 8
- 229910052786 argon Inorganic materials 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 239000012312 sodium hydride Substances 0.000 claims description 3
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 3
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 claims description 2
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000007789 gas Substances 0.000 claims 1
- 239000011435 rock Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 238000006053 organic reaction Methods 0.000 abstract description 5
- 239000002585 base Substances 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 239000003513 alkali Substances 0.000 abstract description 3
- 239000003054 catalyst Substances 0.000 abstract description 3
- 239000012022 methylating agents Substances 0.000 abstract description 3
- 230000035484 reaction time Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 238000011935 selective methylation Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 6
- JHRWCFFXJIFILI-UHFFFAOYSA-N 7-hydroxy-6-methoxy-4-phenylchromen-2-one Chemical compound C=1C(=O)OC=2C=C(O)C(OC)=CC=2C=1C1=CC=CC=C1 JHRWCFFXJIFILI-UHFFFAOYSA-N 0.000 description 5
- HAQWEMHXSIRYBE-UHFFFAOYSA-N 7-hydroxy-8-methoxycoumarin Chemical compound C1=CC(=O)OC2=C1C=CC(O)=C2OC HAQWEMHXSIRYBE-UHFFFAOYSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- QCYBWCHUJBLPBM-UHFFFAOYSA-N 7-hydroxy-6-methoxy-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=C1C=C(OC)C(O)=C2 QCYBWCHUJBLPBM-UHFFFAOYSA-N 0.000 description 4
- JHEDXMVWNCTPTI-UHFFFAOYSA-N 7-hydroxy-8-methoxy-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=C1C=CC(O)=C2OC JHEDXMVWNCTPTI-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000007069 methylation reaction Methods 0.000 description 4
- PGVNVOAMDRDETB-UHFFFAOYSA-N 7-hydroxy-8-methoxy-4-phenylchromen-2-one Chemical compound C=1C(=O)OC=2C(OC)=C(O)C=CC=2C=1C1=CC=CC=C1 PGVNVOAMDRDETB-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000011987 methylation Effects 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 2
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- RQSKEMWBCJHQMX-UHFFFAOYSA-N isoscopoletin Natural products COc1cc2OC(=O)CCc2cc1O RQSKEMWBCJHQMX-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 244000138993 panchioli Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 2
- 229910000105 potassium hydride Inorganic materials 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- KVOJTUXGYQVLAJ-UHFFFAOYSA-N 6,7-dihydroxy-4-methylcoumarin Chemical compound C1=C(O)C(O)=CC2=C1OC(=O)C=C2C KVOJTUXGYQVLAJ-UHFFFAOYSA-N 0.000 description 1
- NWQBYMPNIJXFNQ-UHFFFAOYSA-N 7,8-dihydroxy-4-methyl-1-benzopyran-2-one Chemical compound OC1=C(O)C=CC2=C1OC(=O)C=C2C NWQBYMPNIJXFNQ-UHFFFAOYSA-N 0.000 description 1
- JRVIIPJSVKTPBK-UHFFFAOYSA-N 7,8-dihydroxy-4-phenyl-2h-chromen-2-one Chemical compound C=1C(=O)OC2=C(O)C(O)=CC=C2C=1C1=CC=CC=C1 JRVIIPJSVKTPBK-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- TZRNJQYCOSMOJS-UHFFFAOYSA-N Nordalbergin Chemical compound C1=2C=C(O)C(O)=CC=2OC(=O)C=C1C1=CC=CC=C1 TZRNJQYCOSMOJS-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003527 anti-angiogenesis Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000003880 polar aprotic solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种香豆素儿茶酚类化合物的化学选择性单甲基化方法属于天然药物合成领域,该方法将儿茶酚类香豆素化合物,加入适当碱催化剂的有机反应体系下,与甲基化试剂发生高选择性甲基化反应,进而获得单甲基化产物,所述碱与儿茶酚类香豆素化合物与的摩尔比为:1.0~5.0:1;所述甲基化试剂与儿茶酚类香豆素化合物与的摩尔比为:1.0~2.0:1,所述反应体系温度为‑20~10℃;反应时间为0.5~3小时。该方法具有操作简单、条件温和、选择性好、产率高等特点,可用于具有不同类型取代基团的香豆素儿茶酚类的单甲基化产物制备。The invention provides a chemoselective monomethylation method of coumarin catechol compounds, which belongs to the field of natural medicine synthesis. In the method, catechol coumarin compounds are added into an organic reaction system with a suitable alkali catalyst, A highly selective methylation reaction occurs with a methylating agent to obtain a monomethylated product. The molar ratio of the base to the catechol-like coumarin compound is: 1.0-5.0:1; the methyl The molar ratio of the chemical reagent to the catechol-like coumarin compound is 1.0-2.0:1, the temperature of the reaction system is -20-10°C, and the reaction time is 0.5-3 hours. The method has the characteristics of simple operation, mild conditions, good selectivity, high yield, etc., and can be used for the preparation of monomethylated products of coumarin catechols with different types of substituent groups.
Description
技术领域technical field
本发明属于天然药物合成领域,具体涉及一种香豆素儿茶酚类化合物的化学选择性单甲基化方法。The invention belongs to the field of natural medicine synthesis, and in particular relates to a chemoselective monomethylation method of coumarin catechol compounds.
背景技术Background technique
莨菪亭(6-甲氧基-7-羟基香豆素)、黄檀素(4-苯基-6-甲氧基-7-羟基香豆素)等儿茶酚类香豆素单甲基化产物是一类重要的天然产物,具有多种药理活性。莨菪亭是丁公藤(一种治疗风湿性病的传统中药)中的主要成分之一[Bioorgan.Med.Chem.2013,84],拥有广泛的生物活性,如:抗炎、降尿酸、抗氧化、抗衰老以及抗肿瘤和抑制新血管生成等药理活性[Eur.J.Pharmacol.2007,555,218;Lett.Drug Des.Disc.2012,9,397]。黄檀属植物是一种治疗血管疾病和炎症而闻名的中草药植物,其中的有效成分是黄檀素[Phytochemistry.1997,46,947]。此外,7-羟基-8-甲氧基香豆素被报道能够抑制肝纤维化,起到预防肝硬化的作用[J.Nat.Med.2011,65,370]。然而这类化合物在植物中的含量较低,提取工艺复杂,费时费事[Nat.Prod.Res.2015]。因此,研究此类化合物实用而高效的制备方法对其开发与应用至关重要。目前,所报道的合成方法大都存在实验原料昂贵、需要先进的实验设备、选择性差产率低以及实验条件苛刻等多种缺陷。因此,开发一种新型高效的选择性烷基化技术,制备儿茶酚类香豆素单甲基化产物对此类化合物的开发与利用具有重要价值。Scopoletin (6-methoxy-7-hydroxycoumarin), dalbene (4-phenyl-6-methoxy-7-hydroxycoumarin) and other catechol coumarin monomethylation products It is an important class of natural products with various pharmacological activities. Scopoletin is one of the main components of Dinggongteng (a traditional Chinese medicine for the treatment of rheumatic venereal diseases) [Bioorgan.Med.Chem.2013,84], which has a wide range of biological activities, such as: anti-inflammatory, lowering uric acid, anti-oxidation, anti-inflammatory Aging and anti-tumor and anti-angiogenesis and other pharmacological activities [Eur.J.Pharmacol.2007,555,218; Lett.Drug Des.Disc.2012,9,397]. Dalbergia is a Chinese herbal plant known for treating vascular diseases and inflammations, the active ingredient of which is Dalbergia [Phytochemistry.1997,46,947]. In addition, 7-hydroxy-8-methoxycoumarin has been reported to inhibit liver fibrosis and prevent liver cirrhosis [J.Nat.Med.2011,65,370]. However, the content of such compounds in plants is low, and the extraction process is complicated and time-consuming [Nat.Prod.Res.2015]. Therefore, it is very important to study the practical and efficient preparation methods of such compounds for their development and application. At present, most of the reported synthetic methods have many defects such as expensive experimental raw materials, advanced experimental equipment, poor selectivity, low yield, and harsh experimental conditions. Therefore, the development of a new and efficient selective alkylation technology to prepare catechol coumarin monomethylated products is of great value to the development and utilization of such compounds.
发明内容Contents of the invention
本发明的目的是针对上述现有技术及研究存在的不足,即针对儿茶酚类香豆素不同位置羟基的键能不同,选用恰当的碱催化,在一定有机反应体系下,与甲基化试剂发生高选择性单甲基化反应,制备单甲基化产物。The purpose of the present invention is to address the above-mentioned deficiencies in the prior art and research, that is, for the different bond energies of the hydroxyl groups in different positions of catechol coumarins, select an appropriate base catalysis, and under a certain organic reaction system, react with methylation The reagent undergoes a highly selective monomethylation reaction to prepare a monomethylated product.
本发明一种香豆素儿茶酚类化合物的化学选择性单甲基化方法,将儿茶酚类香豆素化合物,加入适当碱催化剂的有机反应体系下,与甲基化试剂发生高选择性甲基化反应,进而获得单甲基化产物,所述碱与儿茶酚类香豆素化合物与的摩尔比为:1.0~5.0:1;所述甲基化试剂与儿茶酚类香豆素化合物与的摩尔比为:1.0~2.0:1,所述反应体系温度为-20℃~10℃,反应时间为0.5~3小时;The present invention is a chemoselective monomethylation method of coumarin catechol compounds, in which the catechol coumarin compounds are added into an organic reaction system with a suitable alkali catalyst to undergo high selectivity with methylation reagents Methylation reaction, and then obtain the monomethylation product, the molar ratio of the base and the catechol-like coumarin compound is: 1.0~5.0:1; the methylation reagent and the catechol-like aroma The molar ratio of the soy bean compound to: 1.0-2.0:1, the temperature of the reaction system is -20°C-10°C, and the reaction time is 0.5-3 hours;
所述儿茶酚类香豆素化合物结构如为:The structure of the catechol-like coumarin compound is as follows:
其中R为H、(C1-C6)烷基、(C1-C6)烷氧基、芳基、(C1-C6)取代烷基中的任意一种;Wherein R is any one of H, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, aryl, (C 1 -C 6 ) substituted alkyl;
所述单甲基化产物结构式为:The structural formula of the monomethylation product is:
其中R为H、(C1-C6)烷基、(C1-C6)烷氧基、(C1-C6)取代烷基、芳基中的任意一种。Wherein R is any one of H, (C 1 -C 6 ) alkyl, (C 1 -C 6 ) alkoxy, (C 1 -C 6 ) substituted alkyl, and aryl.
所述甲基化试剂为碘甲烷、硫酸二甲酯、三氟甲磺酸甲酯或甲磺酸甲酯中的任意一种或多种组合。The methylating agent is any one or a combination of methyl iodide, dimethyl sulfate, methyl trifluoromethanesulfonate or methyl methanesulfonate.
所述碱催化剂为氢氧化钠、氢氧化钾、氢化钠或氢化钾中的任意一种或多种组合。The alkali catalyst is any one or combination of sodium hydroxide, potassium hydroxide, sodium hydride or potassium hydride.
所述有机反应体系为极性非质子性溶剂,选自N,N-二甲基甲酰胺、四氢呋喃、乙腈或二甲基亚砜中的一种或几种。The organic reaction system is a polar aprotic solvent, one or more selected from N,N-dimethylformamide, tetrahydrofuran, acetonitrile or dimethyl sulfoxide.
所述碱与儿茶酚类香豆素化合物与的摩尔比优选2.5:1。The molar ratio of the base to the catechol-like coumarin compound is preferably 2.5:1.
所述甲基化试剂与儿茶酚类香豆素化合物与的摩尔比优选为:1.1:1。The molar ratio of the methylating agent to the catechol-like coumarin compound is preferably 1.1:1.
所述反应温度优选为-5~5℃。The reaction temperature is preferably -5-5°C.
所述反应时间优选为0.5~1小时。The reaction time is preferably 0.5 to 1 hour.
本发明的特点是以廉价易得的儿茶酚类香豆素(6,7/7,8-二羟基香豆素)或C4-取代的儿茶酚类香豆素为原料,针对其不同位置酚羟基解离能的不同,选用恰当的碱催化,在一定有机反应体系下,与甲基化试剂发生高选择性甲基化反应,制备单甲基化产物。该制备方法具有高选择单甲基化特性的同时还具有工艺简单,操作方便,廉价实用的特点。此制备工艺不仅为制备儿茶酚类香豆素单甲基化产物提供一种切实可用的方法,还为其他儿茶酚类化合物的选择性烷基化提供技术指导。The feature of the present invention is to use cheap and easy-to-get catechol coumarin (6,7/7,8-dihydroxy coumarin) or C4-substituted catechol coumarin as raw material, aiming at its different According to the difference in the dissociation energy of the phenolic hydroxyl group in the position, select the appropriate base to catalyze, and under a certain organic reaction system, a highly selective methylation reaction occurs with a methylating reagent to prepare a monomethylated product. The preparation method has the characteristics of highly selective monomethylation and also has the characteristics of simple process, convenient operation, cheap and practical. This preparation process not only provides a practical method for the preparation of catechol coumarin monomethylation products, but also provides technical guidance for the selective alkylation of other catechol compounds.
附图说明Description of drawings
图1.儿茶酚类香豆素选择性单甲基化产物的制备路线图;Figure 1. The route diagram for the preparation of catechol-like coumarin selective monomethylation products;
图2.6-甲氧基-7-羟基香豆素(Ⅰ-aa)的1H-NMR谱图;Figure 2.1 H-NMR spectrum of 6-methoxy-7-hydroxycoumarin (I-aa);
图3.4-甲基-6-甲氧基-7-羟基香豆素(Ⅰ-ab)的1H-NMR谱图;Figure 3.1 H-NMR spectrum of 4-methyl-6-methoxy-7-hydroxycoumarin (I-ab);
图4.4-苯基-6-甲氧基-7-羟基香豆素(Ⅰ-ac)的1H-NMR谱图;Figure 4.1 H-NMR spectrum of 4 -phenyl-6-methoxy-7-hydroxycoumarin (I-ac);
图5.7-羟基-8-甲氧基香豆素(Ⅱ-aa)的1H-NMR谱图;Figure 5.1 H-NMR spectrum of 7 -hydroxy-8-methoxycoumarin (II-aa);
图6.4-甲基-7-羟基-8-甲氧基香豆素(Ⅱ-ab)的1H-NMR谱图;Figure 6.1 H-NMR spectrum of 4 -methyl-7-hydroxy-8-methoxycoumarin (II-ab);
图7.4-苯基-7-羟基-8-甲氧基香豆素(Ⅱ-ac)的1H-NMR谱图。Fig. 7. 1 H-NMR spectrum of 4-phenyl-7-hydroxy-8-methoxycoumarin (II-ac).
具体实施方式Detailed ways
下面的实施例将对本发明予以进一步的说明,但并不因此而限制本发明。儿茶酚类香豆素化学选择性单甲基化产物的制备路线图如图1所示,具体见以下实施例。The following examples will further illustrate the present invention, but do not limit the present invention thereby. The route diagram for the preparation of chemoselective monomethylated products of catechol coumarins is shown in Figure 1, see the following examples for details.
实施例1Example 1
6-甲氧基-7-羟基香豆素的制备(Ⅰ-aa)Preparation of 6-methoxy-7-hydroxycoumarin (Ⅰ-aa)
称取6,7-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL溶解样品,加冰浴,使反应体系的温度降到-20℃,加入氢化钠280mg,反应液呈粘稠状,充分反应15min后,逐滴加入碘甲烷250μL,维持反应体系的温度在-15~0℃,TLC监测反应进程(VCH2Cl2:VCH3OH=50:1),0.5h后反应结束,将反应液滴加到40mL冰水中,搅拌作用下加入盐酸调节pH,约为3时,有沉淀析出,30min后过滤,收集滤饼,即为粗产品。用15mL乙酸乙酯重结晶,加热回流1h后冷却到室温,过滤,滤饼用乙酸乙酯洗两次,收集滤饼,得白色固体490mg,其1H NMR如图2所示。Weigh 500mg of 6,7-dihydroxycoumarin into a three-necked flask, add 5mL of N,N-dimethylformamide under the protection of argon to dissolve the sample, and add an ice bath to lower the temperature of the reaction system to -20°C. Add 280 mg of sodium hydride, and the reaction solution is viscous. After fully reacting for 15 minutes, add 250 μL of methyl iodide dropwise to maintain the temperature of the reaction system at -15 to 0 ° C. TLC monitors the progress of the reaction (V CH2Cl2 : V CH3OH = 50:1 ), after 0.5h, the reaction was completed, and the reaction solution was added dropwise to 40mL of ice water, and hydrochloric acid was added under stirring to adjust the pH. At about 3 o'clock, a precipitate was precipitated, filtered after 30min, and the filter cake was collected, which was the crude product. Recrystallize with 15 mL of ethyl acetate, heat to reflux for 1 h, cool to room temperature, filter, wash the filter cake twice with ethyl acetate, collect the filter cake to obtain 490 mg of white solid, its 1 H NMR is shown in Figure 2.
1H NMR(500MHz,DMSO-d6)δ:3.82(s,3H,OCH3),6.22(d,J=9.5Hz,1H,COCH=C),6.78(s,1H,Ar-H),7.22(s,1H,Ar-H),7.91(d,J=9.5Hz,1H,C=CH),10.29(d,br,1H,Ar-OH) 1 H NMR (500MHz, DMSO-d 6 )δ: 3.82(s, 3H, OCH 3 ), 6.22(d, J=9.5Hz, 1H, COCH=C), 6.78(s, 1H, Ar-H), 7.22 (s, 1H, Ar-H), 7.91 (d, J=9.5Hz, 1H, C=CH), 10.29 (d, br, 1H, Ar-OH)
实施例2Example 2
4-甲基-6-甲氧基-7-羟基香豆素(Ⅰ-ab)的制备Preparation of 4-methyl-6-methoxy-7-hydroxycoumarin (Ⅰ-ab)
称取4-甲基-6,7-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL溶解样品,加冰水浴,使反应体系的温度降到-10℃以下,加入氢氧化钾660mg,充分反应15min后,逐渐滴加碘甲烷210μL,维持体系的反应温度在-10~0℃,TLC监测反应进程,2h后反应结束,搅拌下将反应液逐滴滴加到40mL冰水中,加稀盐酸调pH到3~4,有沉淀析出,30min后过滤,收集滤饼,即为粗产品。粗品用乙酸乙酯重结晶,加热回流1h,冷却后过滤,收集滤饼,真空干燥,得白色固体440mg,其1H NMR如图3所示。Weigh 500 mg of 4-methyl-6,7-dihydroxycoumarin into a three-necked flask, add 5 mL of N,N-dimethylformamide to dissolve the sample under the protection of argon, and add an ice-water bath to lower the temperature of the reaction system. When the temperature is below -10°C, add 660 mg of potassium hydroxide, and after fully reacting for 15 minutes, gradually add 210 μL of iodomethane dropwise to maintain the reaction temperature of the system at -10~0°C, TLC Monitor the progress of the reaction. After 2 hours, the reaction ends. Add the reaction solution dropwise to 40 mL of ice water with stirring, and adjust the pH to 3-4 with dilute hydrochloric acid. Precipitation occurs. After 30 minutes, filter and collect the filter cake, which is the crude product. The crude product was recrystallized from ethyl acetate, heated to reflux for 1 h, filtered after cooling, and the filter cake was collected and dried in vacuo to obtain 440 mg of a white solid, whose 1 H NMR is shown in Figure 3 .
1H NMR(400MHz,DMSO-d6)δ:2.40(s,3H,CH3),3.85(s,3H,OCH3),6.13(s,1H,COCH=C),6.90(s,1H,Ar-H),7.13(s,1H,Ar-H),10.53(s,1H,OH). 1 H NMR (400MHz, DMSO-d 6 )δ: 2.40(s,3H,CH 3 ),3.85(s,3H,OCH 3 ),6.13(s,1H,COCH=C),6.90(s,1H, Ar-H),7.13(s,1H,Ar-H),10.53(s,1H,OH).
实施例3Example 3
4-苯基-6-甲氧基-7-羟基香豆素(Ⅰ-ac)的制备Preparation of 4-phenyl-6-methoxy-7-hydroxycoumarin (Ⅰ-ac)
称取4-苯基-6,7-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL溶解样品,加冰水浴,使反应体系的温度降到0℃,加入氢氧化钠360mg,充分反应15min后,逐渐滴加碘甲烷190μL,维持体系的反应温度在0~10℃,TLC监测反应进程,3h后反应结束,搅拌下将反应液逐滴滴加到40mL冰水中,加稀盐酸调pH到3~4,有沉淀析出,30min后过滤,收集滤饼,即为粗产品。粗品用甲醇重结晶,加热回流1h,冷却后过滤,收集滤饼,真空干燥,得白色固体380mg,其1H NMR如图4所示。Weigh 500 mg of 4-phenyl-6,7-dihydroxycoumarin into a three-necked flask, add 5 mL of N,N-dimethylformamide to dissolve the sample under the protection of argon, and add an ice-water bath to lower the temperature of the reaction system. to 0°C, add 360 mg of sodium hydroxide, and after fully reacting for 15 minutes, gradually add 190 μL of iodomethane dropwise to maintain the reaction temperature of the system at 0-10°C, TLC Monitor the reaction process, the reaction is over after 3 hours, add the reaction solution drop by drop to 40mL ice water with stirring, add dilute hydrochloric acid to adjust the pH to 3-4, there is precipitation, filter after 30 minutes, and collect the filter cake, which is the crude product. The crude product was recrystallized from methanol, heated to reflux for 1 h, filtered after cooling, and the filter cake was collected and dried in vacuo to obtain 380 mg of white solid, whose 1 H NMR is shown in Figure 4 .
1H NMR(500MHz,DMSO-d6)δ:3.67(s,3H,OCH3),6.17(s,1H,COCH=C),6.83(s,1H,Ar-H),6.89(s,1H,Ar-H),7.58(s,5H,Ar-H),10.47(s,br,1H,Ar-OH). 1 H NMR (500MHz, DMSO-d 6 ) δ: 3.67(s,3H,OCH 3 ), 6.17(s,1H,COCH=C), 6.83(s,1H,Ar-H), 6.89(s,1H ,Ar-H),7.58(s,5H,Ar-H),10.47(s,br,1H,Ar-OH).
实施例4Example 4
7-羟基-8-甲氧基香豆素(Ⅱ-aa)的制备Preparation of 7-Hydroxy-8-methoxycoumarin (Ⅱ-aa)
称取7,8-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL,加冰浴使反应体系的温度降到-20℃,加入氢化钾330mg,反应15min后,,逐滴加入碘甲烷220μL,维持反应体系的温度在-20~-5℃,TLC监测反应进程,0.5h后反应结束,将反应液滴加到100mL冰水中,加盐酸调节pH约为3,乙酸乙酯萃取(50mL×3),合并乙酸乙酯相,饱和食盐水洗两次,有机相减压蒸馏去除乙酸乙酯,即为粗品,粗品经硅胶柱分离,流动相为V石油醚:V二氯甲烷:V丙酮=2:1:0.15,减压蒸馏去除溶剂,真空干燥,得白色固体370mg,其1H NMR如图5所示。Weigh 500 mg of 7,8-dihydroxycoumarin into a three-neck flask, add 5 mL of N,N-dimethylformamide under argon protection, add an ice bath to lower the temperature of the reaction system to -20 °C, add potassium hydride After reacting for 15 minutes, add 220 μL of methyl iodide dropwise to maintain the temperature of the reaction system at -20~-5 °C. TLC monitors the reaction process. After 0.5 hours, the reaction is completed. Add the reaction solution dropwise to 100 mL of ice water, add hydrochloric acid Adjust the pH to about 3, extract with ethyl acetate (50mL×3), combine the ethyl acetate phases, wash with saturated brine twice, and distill the organic phase under reduced pressure to remove ethyl acetate, which is the crude product, which is separated by a silica gel column, and the mobile phase V petroleum ether : V dichloromethane : V acetone = 2:1:0.15, distilled off the solvent under reduced pressure, and dried in vacuo to obtain 370 mg of white solid, whose 1 H NMR is shown in Figure 5.
1H NMR(400MHz,DMSO-d6)δ:3.82(s,3H,OCH3),6.22(d,J=9.2Hz,1H,COCH=C),6.85(d,1H,J=8.4Hz,Ar-H),7.26(d,1H,J=8.4Hz,Ar-H),7.92(d,J=9.2,1H,C=CH),10.38(s,1H,Ar-OH). 1 H NMR (400MHz, DMSO-d 6 )δ: 3.82(s, 3H, OCH 3 ), 6.22(d, J=9.2Hz, 1H, COCH=C), 6.85(d, 1H, J=8.4Hz, Ar-H), 7.26(d, 1H, J=8.4Hz, Ar-H), 7.92(d, J=9.2, 1H, C=CH), 10.38(s, 1H, Ar-OH).
实施例5Example 5
4-甲基-7-羟基-8-甲氧基香豆素(Ⅱ-ab)的制备Preparation of 4-methyl-7-hydroxy-8-methoxycoumarin (Ⅱ-ab)
称取4-甲基-7,8-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL溶解底物,加冰浴,使反应体系的温度降到-10℃以下,加入氢氧化钾380mg,反应20min后,逐滴加入碘甲烷280μL,维持反应体系的温度在-10~0℃左右,TLC监测反应进程,0.5h后反应结束,将反应液滴加到100mL冰水中,加盐酸调节pH约为3,乙酸乙酯萃取(50mL×3),合并乙酸乙酯相,饱和食盐水洗两次,有机相减压蒸馏去除乙酸乙酯,即为粗品,粗品经硅胶柱分离,流动相为V石油醚:V二氯甲烷:V丙酮=2:1:0.15,减压蒸馏去除溶剂,真空干燥,得白色固体326mg,其1H NMR如图6所示。Weigh 500 mg of 4-methyl-7,8-dihydroxycoumarin into a three-necked flask, add 5 mL of N,N-dimethylformamide under the protection of argon to dissolve the substrate, add an ice bath, and bring the temperature of the reaction system to When the temperature drops below -10°C, add 380 mg of potassium hydroxide. After 20 minutes of reaction, add 280 μL of iodomethane dropwise to maintain the temperature of the reaction system at about -10 to 0°C. TLC monitors the reaction process. After 0.5 hours, the reaction is completed. The liquid was added dropwise to 100 mL of ice water, hydrochloric acid was added to adjust the pH to about 3, extracted with ethyl acetate (50 mL×3), the ethyl acetate phase was combined, washed twice with saturated brine, and the organic phase was distilled under reduced pressure to remove the ethyl acetate, which was Crude product, the crude product was separated by a silica gel column, the mobile phase was V petroleum ether : V dichloromethane : V acetone = 2:1:0.15, the solvent was distilled off under reduced pressure, and dried in vacuo to obtain 326 mg of a white solid. Its 1 H NMR is shown in Figure 6 shown.
1H NMR(400MHz,DMSO-d6)δ:2.36(s,3H,CH3),3.82(s,3H,OCH3),6.16(s,1H,COCH=C),6.88(d,J=8,1H,Ar-H),7.35(d,J=8,1H,Ar-H),10.33(s,1H,OH). 1 H NMR (400MHz, DMSO-d 6 ) δ: 2.36(s,3H,CH 3 ), 3.82(s,3H,OCH 3 ), 6.16(s,1H,COCH=C), 6.88(d,J= 8,1H,Ar-H),7.35(d,J=8,1H,Ar-H),10.33(s,1H,OH).
实施例6Example 6
4-苯基-7-羟基-8-甲氧基香豆素(Ⅱ-ac)的制备Preparation of 4-phenyl-7-hydroxy-8-methoxycoumarin (Ⅱ-ac)
称取4-苯基-7,8-二羟基香豆素500mg于三口瓶中,氩气保护下加入N,N-二甲基甲酰胺5mL溶解底物,加冰浴,使反应体系的温度降到0℃,加入氢氧化钠240mg,反应25min后,逐滴加入碘甲烷250μL,维持反应体系的温度反应在0~10℃,TLC监测反应进程,0.5h后反应结束,将反应液滴加到100mL冰水中,加盐酸调节pH约为3,有沉淀析出,30min后过滤,收集滤饼,即为粗产品。粗品经硅胶柱分离,流动相为V石油醚:V乙酸乙酯:V甲醇=4:1:0.1,减压蒸馏去除有机溶剂,得白色略带黄色针状固体280mg,其1H NMR如图7所示。Weigh 500 mg of 4-phenyl-7,8-dihydroxycoumarin into a three-necked flask, add 5 mL of N,N-dimethylformamide under the protection of argon to dissolve the substrate, add an ice bath, and bring the temperature of the reaction system to Drop to 0°C, add 240 mg of sodium hydroxide, and react for 25 minutes, then add 250 μL of methyl iodide dropwise to maintain the temperature of the reaction system at 0-10°C, monitor the progress of the reaction by TLC. Add hydrochloric acid to adjust the pH to about 3 in 100mL of ice water. After 30 minutes, filter and collect the filter cake, which is the crude product. The crude product was separated on a silica gel column, the mobile phase was V petroleum ether : V ethyl acetate : V methanol = 4:1:0.1, and the organic solvent was removed by distillation under reduced pressure to obtain 280 mg of a white slightly yellow needle-like solid. Its 1 H NMR is shown in the figure 7.
1H NMR(500MHz,DMSO-d6)δ:3.87(s,3H,OCH3),6.18(s,1H,COCH=C),6.86(d,J=9Hz,1H,Ar-H),7.02(d,J=9Hz,1H,Ar-H),7.50-7.57(m,5H,Ar-H),10.49(s,br,1H,Ar-OH) 1 H NMR (500MHz, DMSO-d 6 ) δ: 3.87 (s, 3H, OCH 3 ), 6.18 (s, 1H, COCH=C), 6.86 (d, J=9Hz, 1H, Ar-H), 7.02 (d,J=9Hz,1H,Ar-H),7.50-7.57(m,5H,Ar-H),10.49(s,br,1H,Ar-OH)
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510574322.1A CN106518825B (en) | 2015-09-10 | 2015-09-10 | A kind of chemoselective monomethylation method of coumarin catechol compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510574322.1A CN106518825B (en) | 2015-09-10 | 2015-09-10 | A kind of chemoselective monomethylation method of coumarin catechol compound |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106518825A CN106518825A (en) | 2017-03-22 |
CN106518825B true CN106518825B (en) | 2019-10-11 |
Family
ID=58346105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510574322.1A Expired - Fee Related CN106518825B (en) | 2015-09-10 | 2015-09-10 | A kind of chemoselective monomethylation method of coumarin catechol compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106518825B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102702155A (en) * | 2012-06-15 | 2012-10-03 | 南京中医药大学 | Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product |
WO2012174488A2 (en) * | 2011-06-15 | 2012-12-20 | Nono, Inc. | Agents and methods for treating ischemic and other diseases |
-
2015
- 2015-09-10 CN CN201510574322.1A patent/CN106518825B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012174488A2 (en) * | 2011-06-15 | 2012-12-20 | Nono, Inc. | Agents and methods for treating ischemic and other diseases |
CN102702155A (en) * | 2012-06-15 | 2012-10-03 | 南京中医药大学 | Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product |
Non-Patent Citations (4)
Title |
---|
An Expedient Method for Regioselective Methylation of Catechol Coumarins;LU Junxia et al;《Chem. Res. Chin. Univ.》;20160917;第32卷(第5期);第786-791页 * |
Chemical conversion of fraxin into isofraxidin;Gorecki P. et al;《Herba Polonica》;19881231;第34卷(第1-2期);第43-50页 * |
Lamellarins as Inhibitors of P-Glycoprotein-Mediated Multidrug Resistance in a Human Colon Cancer Cell Line;Fabien Plisson et al;《Chem. Asian J.》;20120330;第7卷(第7期);第1616-1623页,尤其是第1620页右栏Figure 8、第S4页倒数第1段-第S5页第1段 * |
Synthesis of methyl-substituted xanthotoxol to clarify prooxidant effect of methyl on radical-induced oxidation of DNA;Chuan Xiao et al;《European Journal of Medicinal Chemistry》;20100304;第45卷;第2559-2566页,尤其是第2560页Scheme 2及第2563页右栏第6.2.3节 * |
Also Published As
Publication number | Publication date |
---|---|
CN106518825A (en) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102267985B (en) | The preparation method of vilazodone or its hydrochloride | |
EP2844647B1 (en) | Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals | |
CN103524588B (en) | A kind of method preparing Progesterone | |
Pan et al. | Total synthesis of 8-(6 ″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents | |
TW201309662A (en) | A novel synthesis process of polyphenols | |
Xiao et al. | Design, synthesis and antitumor activity of a series of novel coumarin–stilbenes hybrids, the 3-arylcoumarins | |
CN106518825B (en) | A kind of chemoselective monomethylation method of coumarin catechol compound | |
CN102516219B (en) | Halogenated polyhydroxy xanthene derivatives, preparation method and use thereof | |
Kuramochi et al. | Synthesis and structure–activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors | |
CN102126942A (en) | Method for synthesizing hypericin | |
CN106518826A (en) | High-selectivity preparation method for 7-methoxy-6/8-hydroxy coumarin | |
KR102393639B1 (en) | Dimethylchalcone derivatives and preparation method thereof | |
JP7550981B2 (en) | Methods for the preparation of cannabis flavonoids | |
CN102020662A (en) | Method for preparing torisel | |
CN106554362A (en) | A kind of copper chloride (II) chelate and its synthetic method and application with 1 pyridine β carbolines as part | |
CN106543208A (en) | Copper chloride (II) chelate and its synthetic method and application with 1 pyridine β carbolines as part | |
CN115181112B (en) | Synthesis of 3,4-diketone Derivatives of 6-Bromocyclo-Epimedium Chroman and Its Antitumor Application | |
CN110684003A (en) | A simple and efficient total synthesis method of icariin and its derivatives | |
CN112745314B (en) | Preparation and synthesis method of aromatic amine compound with specific HIF-2 alpha inhibition effect | |
CN115073485B (en) | 3-aryl-7, 8-pyranocoumarin derivative, and preparation method and application thereof | |
CN115215879B (en) | 3-aryl-4, 5-pyranocoumarin derivative, and preparation method and application thereof | |
CN102212099A (en) | Synthesis method for dehydroepiandrosterone | |
JP5712580B2 (en) | Process for producing 5,7-dihydroxy-6-methoxyflavones | |
CN117903054A (en) | Sulfur-containing o-hydroxyphenyl pyrazole compound, and preparation method and application thereof | |
WO2022099931A1 (en) | Preparation method for cannflavin compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20191011 |